Aberrant Activation of Cell Cycle Regulators, Centrosome Amplification, and Mitotic Defects

Hormones and Cancer

Volumn 2, Issue 2, 2011, Pages 104-112

  Fukasawa, Kenji ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; CDK2; Centrosome amplification; Centrosomes; Met; Nucleophosmin; Receptor tyrosine kinase; Rho ROCK2 pathway

Indexed keywords

APHIDICOLIN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; HORMONE RECEPTOR; HYDROXYUREA; NUCLEOPHOSMIN; PROTEIN P21; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN X; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SCATTER FACTOR RECEPTOR;

ARTICLE; BLADDER CANCER; CANCER TISSUE; CELL CYCLE REGULATION; CELL EXPANSION; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME DUPLICATION; DNA REPLICATION; ENZYME ACTIVATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; MITOSIS; MITOSIS SPINDLE; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CENTROSOME; HUMANS; MITOSIS; NEOPLASMS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 79952627200     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-010-0060-4     Document Type: Article

References (52)

1. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
2. Doxsey S (2002) Re-evaluating centrosome function. Nat Rev Mol Cell Biol 2: 688-698.
3. Fukasawa K (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230: 6-19.
4. Fukasawa K (2007) Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 7: 911-924.
5. Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18-21.
6. D'Assoro AB, Lingle WL, Salisbury JL (2002) Centrosome amplification and the development of cancer. Oncogene 21: 6146-6153.
7. Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra centrosomes to chromosomal instability. Nature 460: 278-282.
8. Ma Z, Kanai M, Kawamura K et al (2006) Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol 26: 9016-9034.
9. Hinchcliffe EH, Sluder G (2001) It takes two to tango: understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev 15: 1167-1181.
10. Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429.
11. Hinchcliffe EH, Li C, Thompson EA et al (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283: 851-854.
12. Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 96: 2817-2822.
13. Matsumoto Y, Hayashi K, Nishida E (1999) Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9: 429-432.
14. Tarapore P, Okuda M, Fukasawa K (2002) A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and Nucleophosmin/B23 in centrosome duplication. Cell Cycle 1: 75-81.
15. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815.
16. Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6: 663-673.
17. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K et al (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
18. Harper JW (1997) Cyclin dependent kinase inhibitors. Cancer Surv 29: 91-107.
19. Kawamura K, Izumi H, Ma Z et al (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64: 4800-4809.
20. D'Assoro AB, Lingle WL, Salisbury JL (2004) Centrosome amplification and the origin of chromosomal instability in breast cancer. Mammary Gland Biol Neoplasia 9: 275-283.
21. Koutsami MK, Tsantoulis PK, Kouloukoussa M et al (2006) Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression. J Pathol 209: 512-521.
22. Weber RG, Bridger JM, Benner A et al (1998) Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet Cell Genet 83: 266-269.
23. Carroll PE, Okuda M, Horn HF et al (1999) Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18: 1935-1944.
24. Pihan GA, Wallace J, Zhou Y et al (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63: 1398-1404.
25. Nakajima T, Moriguchi M, Mitsumoto Y et al (2004) Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Mod Pathol 17: 722-727.
26. Mussman JG, Horn HF, Carroll PE et al (2000) Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19: 1635-1646.
27. Okuda M, Horn HF, Tarapore P et al (2000) Nucleophosmin/B23 is a target of CDK2-cyclin E in centrosome duplication. Cell 103: 127-140.
28. Fisk HA, Winey A (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106: 95-104.
29. Chen Z, Indjeian VB, McManus M et al (2002) CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3: 339-350.
30. Szebeni A, Olson MO (1999) Nucleolar protein B23 has molecular chaperone activities. Protein Sci 8: 905-912.
31. Takemura M, Sato K, Nishio M et al (1999) Nucleolar protein B23. 1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity. J Biochem 125: 904-909.
32. Valdez BC, Perlaky L, Henning D et al (1994) Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. J Biol Chem 269: 23776-23783.
33. Tarapore P, Shinmura K, Suzuki H et al (2006) Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing. FEBS Lett 580: 399-409.
34. Colombo E, Marine JC, Danovi D et al (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4: 529-533.
35. Bertwistle D, Sugimoto M, Sherr CJ (2004) Physical and functional interactions of the Arf tumor suppressor protein with Nucleophosmin/B23. Mol Cell Biol 24: 985-996.
36. Korgaonkar C, Hagen J, Tompkins V et al (2005) Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 25: 1258-1271.
37. Tokuyama Y, Horn HF, Kawamura K et al (2001) Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276: 21529-21537.
38. Grisendi S, Bernardi R, Rossi M et al (2005) Role of Nucleophosmin in embryonic development and tumorigenesis. Nature 437: 147-153.
39. Leung T, Chen XQ, Manser E et al (1996) The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16: 5313-5327.
40. Matsui T, Amano M, Yamamoto T et al (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15: 2208-2216.
41. Nakagawa O, Fujisawa K, Ishizaki T et al (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392: 189-193.
42. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 692-695.
43. Amano M, Ito M, Kimura K et al (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249.
44. Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301: 43-49.
45. Kanai M, Crowe MS, Zheng Y et al (2010) RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication. Oncogene 29(45): 6040-6050.
46. Fujisawa K, Madaule P, Ishizaki T et al (1998) Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules. J Biol Chem 273: 18943-18949.
47. Sahai E, Alberts AS, Treisman R (1998) RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17: 1350-1361.
48. Vega FM, Ridley AJ (2008) RhoGTPases in cancer cell biology. FEBS Lett 582: 2093-2101.
49. Schiller MR (2006) Coupling receptor tyrosine kinases to Rho GTPases-GEFs what's the link. Cell Signal 18: 1834-1843.
50. Sherline P, Mascardo RN (1982) Epidermal growth factor induces rapid centrosomal separation in HeLa and 3T3 cells. J Cell Biol 93: 507-511.
51. Balczon R, Bao L, Zimmer WE et al (1995) Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 130: 105-115.
52. Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF (2004) RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 64: 7962-7970.